Major players in the single-chamber prefilled syringes market are BD, Gerresheimer, Schott, Catalent, Nipro, Weigao, Stevanato, Baxter, Vetter Pharma, and Terumo.
The global single-chamber prefilled syringes market is expected to grow from $4.41 billion in 2020 to $4.97 billion in 2021 at a compound annual growth rate (CAGR) of 12.7%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $7.58 billion in 2025 at a CAGR of 11.1%.
The single-chamber prefilled syringes market consists of sales of single-chamber prefilled syringes by entities (organizations, sole traders, and partnerships) that manufacture disposable single-chamber syringes with already loaded liquid medicine to be injected. The companies involved in the single-chamber prefilled syringes market are primarily engaged in the development, manufacturing, and marketing of single-chamber prefilled syringes.
The main types of products in single-chamber prefilled syringes are glass and plastic.A glass-based single-chamber prefilled syringe is a type of single-chamber prefilled syringe manufactured using glass.
Glass is the most preferred material for manufacturing prefilled syringes.A plastic-based single-chamber prefilled syringe uses plastic as the preferred material.
These single-chamber prefilled syringes are used for injecting prefilled vaccine products, biological, or pharmaceutical products.
The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
The growing technological advancements are shaping the single-chamber prefilled syringe market.Major companies operating in the single-chamber prefilled syringe sector are focused on developing technological solutions for the single-chamber prefilled syringe market to strengthen their position.
For instance, in 2019, Biocorp, a France-based medical device manufacturing company launched Injay, a single-chamber prefilled syringe that uses Near Field Communication (NFC) chip to stores information regarding drug name, batch number, and expiry date and transfers this data when it is scanned using the code provided. This information will be transmitted from the patient’s phone to the doctor with the specified date and time when the patient injected the drug.
In October 2020, Credence Medsystems, US-based drug delivery, and specialty pharmaceutical company has collaborated with Schott AG, a German-based glass and glass-ceramics manufacturing company. The collaboration is to integrate Credence’s Companion technology with Schott’s refillable syringe glass and polymer syringe systems and provide an innovative and differentiated offering for the delivery of injectable medications via prefilled syringes.
The growing prevalence of chronic diseases such as diabetes, cancers are contributing to the growth of the single-chamber prefilled syringes market.According to the International Diabetes Federation, in 2019, approximately 463 million adults are living with diabetes and by 2045 it is estimated to be 700 million adults around the world, and 1 in 5 adults above 65 will have diabetes.
According to the American Cancer Society, in 2021, 1.9 million new cancer cases would be registered. Diabetes patients who require insulin therapy when medicines could not control their blood glucose levels, the diabetes patients use the single-chamber prefilled syringe. Therefore, the growing prevalence of chronic diseases such as diabetes and cancers drives the market for single-chamber prefilled syringes.
The countries covered in the single-chamber prefilled syringes market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Our reports have been used by over 10K customers, including:
250 pages •
By The Business Research Company
• May 2022
Major players in the injectable drug delivery devices market are Becton, Dickinson and Company, Gerresheimer AG, Eli Lilly and Company, Pfizer Inc, Teva Pharmaceutical Industries Ltd, Schott AG, Baxter International, Owen Mumford, Mylan N.V., and Sanofi. The global injectable drug delivery devices market is expected to grow from $34.49...
432 pages •
By Global Industry Analysts
• Mar 2022
Abstract: What`s New for 2022? - Global competitiveness and key competitor percentage market shares - Market presence across multiple geographies - Strong/Active/Niche/Trivial - Online interactive peer-to-peer collaborative bespoke updates - Access to our digital archives and MarketGlass Research Platform - Complimentary...
The Latin America, Middle East and Africa Vegetarian Softgel Capsules Market would witness market growth of 7.0% CAGR during the forecast period (2021-2027). Softgel capsules provide several advantages, including ease of ingesting, increased bioavailability, odor & taste masking, enhanced absorption, and good atmospheric stability....
The global pen needles market reached a value of US$2.8 Billion in 2021. Looking forward, the analyst expects the market to reach US$6.5 Billion by 2027, exhibiting a CAGR of 15.01% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the...
Wearable Injectors Market By Type (On-Body and Off-Body), Usage (Disposable and Semi-Reusable), Technology (Electronic, Mechanical, and Others), Mechanism Of Injection (Motor Driven, Spring Driven, Expanding Battery, Rotary Pump, Collapsible Reservoir, and Pressurized Gas), Therapeutic Area (Diabetes, Oncology, Cardiovascular Disease,...
250 pages •
By The Business Research Company
• May 2022
Major players in the drug delivery devices market are F. Hoffmann-La Roche Ltd, 3M Company, Pfizer Inc, Baxter International, BD, Novartis AG, Gerresheimer AG, Johnson & Johnson Services, Inc, Bayer AG, and GlaxoSmithKline plc. The global drug delivery devices market is expected to grow from $79.68 billion in 2021 to $84.1 billion in...
120 pages •
By Infiniti Research Limited
• Apr 2022
Global Smart Pills Drug Delivery Market 2022-2026 The analyst has been monitoring the smart pills drug delivery market and it is poised to grow by $ 4.69 bn during 2022-2026 progressing at a CAGR of 18.66% during the forecast period. Our report on the smart pills drug delivery market provides a holistic analysis, market...
250 pages •
By The Business Research Company
• May 2022
Major players in the smart pills market are Medtronic Plc., Olympus Medical Technology, CapsoVision, Inc., Novartis AG, Proteus Pharmaceuticals, Philips Healthcare, Microchips, Bio-Images Drug Delivery (BDD) Limited, Given Imaging, Inc., and Vitality. The global smart pills market is expected to grow from $4.03 billion in 2021 to $4.48...
The global drug device combination products market reached a value of US$ 132.45 Billion in 2021. Looking forward, the analyst expects the market to reach US$ 214.53 Billion by 2027, exhibiting at a CAGR of 8.27% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well...
175 pages •
By The Business Research Company
• Mar 2022
Major players in the diuretic market are Merck & Co., Meda Manufacturing GmbH, Pfizer Inc., Glaxosmithkline, Roche, Aton Pharma Inc., Boehringer Ingelheim GmbH, Novartis AG and Teva Pharmaceuticals Industries Ltd. The global diuretics market is expected to grow from $0.60 billion in 2021 to $0.64 billion in 2022 at a compound annual...
Pharmaceutical
Drug Delivery
World
United States
United Kingdom
Japan
Middle East
APAC
By continuing to use this site you consent to the use of cookies on your device as described in our Cookie Policy unless you have disabled them.
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.